Thioridazine Hydrochloride
Specifications
130-61-0CAS Number
204-992-8EC Number
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochlorideIUPAC Name
C21H27ClN2S2Chemical Formula
407 g/molMolecular Weight
Thioridazine hydrochloride; 130-61-0; Thioridazine Hcl; Sonapax hydrochloride; Mellaril hydrochloride; Ridazine; DTXSID9049401; 4WCI67NK8M; NSC-186060; Thioridazine hydrochloride intensol; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine hydrochloride; DTXCID3029360; CHEBI:48566; NSC186060; 2-Methylmercapto-10-[2-(N-methyl-2-piperidyl)ethyl]phenothiazine hydrochloride; RefChem:56612; 10-(2-((2RS)-1-Methylpiperidin-2-yl)ethyl)-2-methylsulfanyl-10H-phenothiazine monohydrochloride; 204-992-8; Thioridazine.HCl; Thioridazine chloride; Aldazine; USAF SZ-B; USAF SZ-3; Thioridazine (hydrochloride); 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine hydrochloride; MFCD00012655; MLS000028408; C21H27ClN2S2; s5563; 10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-, monohydrochloride; SMR000058380; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylthiophenothiazine hydrochloride; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine monohydrochloride; Melleril (tablet); Melzine; 10-(2-(1-methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine hydrochloride; 10-[2-(1-Methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine Hydrochloride; 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-, monohydrochloride; Thioridazine hydrochloride [JAN]; EINECS 204-992-8; UNII-4WCI67NK8M; NSC 186060; Tioridazin; Metlaril; SR-01000000063; 10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylthiophenothiazine hydrochloride; 10-[2-(1-Methyl-2-piperidyl)ethyl]-2-(methylthio)phenothiazine monohydrochloride; Mellaril (TN); Prestwick_437; Thioridazine hydrochloride [USP:JAN]; Thoridazine hydrochloride; Opera_ID_1713; CAS-130-61-0; 10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylthio)-10H-phenothiazine hydrochloride; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochloride; SCHEMBL41430; MLS001148599; MLS002222212; SPECTRUM1500575; Thioridazine hydrochloride CRS; THIORIDAZINEHYDROCHLORIDE; orb1226583; orb1310686; orb3141221; CHEMBL1200916; SCHEMBL29387384; SCHEMBL30827481; HY-B0965R; NZFNXWQNBYZDAQ-UHFFFAOYSA-N; GLXC-06106; HMS1568O17; HMS1921E11; HMS5084F20; Pharmakon1600-01500575; HY-B0965; MSK10372; Thioridazine hydrochloride, >=99%; Tox21_202801; Tox21_501252; CCG-39270; EBC-07856; NSC757349; SBB057665; AKOS015994763; CS-4450; FT28238; KS-5108; LP01252; NC00594; NSC-757349; Thioridazine hydrochloride (JP17/USP); THIORIDAZINE HYDROCHLORIDE [MI]; Phenothiazine, 10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylthio)-, monohydrochloride; Thioridazine (hydrochloride) (Standard); NCGC00094492-01; NCGC00094492-02; NCGC00094492-03; NCGC00094492-04; NCGC00094492-05; NCGC00260347-01; NCGC00261937-01; SY104369; THIORIDAZINE HYDROCHLORIDE [MART.]; THIORIDAZINE HYDROCHLORIDE [VANDF]; THIORIDAZINE HYDROCHLORIDE [USP-RS]; THIORIDAZINE HYDROCHLORIDE [WHO-DD]; DB-041975; EU-0101252; NS00079148; ST50412003; SW196660-3; D00798; D82085; EN300-127029; T 9025; THIORIDAZINE HYDROCHLORIDE [ORANGE BOOK]; THIORIDAZINE HYDROCHLORIDE [EP MONOGRAPH]; F952101; THIORIDAZINE HYDROCHLORIDE [USP MONOGRAPH]; Thioridazine inverted exclamation mark currencyHCl; SR-01000000063-2; SR-01000000063-7; Q27104616; Thioridazine.HCl, 1mg/ml in Methanol (as free base); WLN: T C666 BN ISJ ES1 B2-BT6NTJ A1 & GH; Z1592690502; Thioridazine Hydrochloride 1.0 mg/ml in Methanol (as free base); 10-[2-(1-methyl(2-piperidyl))ethyl]-2-methylthiophenothiazine, chloride; Thioridazine hydrochloride, European Pharmacopoeia (EP) Reference Standard; 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine;hydrochloride; Thioridazine hydrochloride, United States Pharmacopeia (USP) Reference Standard; 10-[2-(1-Methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine--hydrogen chloride (1/1)Synonyms
